Errata (DOI:10.1016/S1470-2045(07)70208-5);Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study

Lancet Oncology

Volumn 8, Issue 8, 2007, Pages 696-705

  Grundy, Richard G ^a   Wilne, Sophie A ^a   Weston, Claire L ^b   Robinson, Kath ^b   Lashford, Linda S ^b   Ironside, James ^c   Cox, Tim ^d   Chong, W Kling ^d   Campbell, Richard HA ^b   Bailey, Cliff C ^b   Gattamaneni, Rao ^b   Picton, Sue ^e   Thorpe, Nicky ^f   Mallucci, Conor ^f   English, Martin W ^g   Punt, Jonathan AG ^a   Walker, David A ^a   Ellison, David W ^h   Machin, David ^b,i  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c NHS LOTHIAN   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^g BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^h NATIONAL HEALTH SERVICE   (United Kingdom)

ⁱ DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; FOLINIC ACID; MESNA; METHOTREXATE; VINCRISTINE;

ARTICLE; BLOOD TOXICITY; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER RELAPSE; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG BLOOD LEVEL; DRUG MEGADOSE; EPENDYMOMA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUROIMAGING; NEUROSURGERY; OTOTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 34547540063     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70257-7     Document Type: Erratum

References (47)

1. Bouffet E., Perilongo G., Canete A., and Massimino M. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 30 (1998) 319-329
2. Grill J., Le Deley M., Gambarelli D., et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19 (2001) 1288-1296
3. Duffner P., Horowitz M., Krischer J., et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328 (1993) 1725-1731
4. Merchant T., Mulhern R., Krasin M., et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 22 (2004) 3156-3162
5. Geyer J., Sposto R., Jennings M., et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 23 (2005) 7621-7631
6. Geyer J., Zeltzer P., Boyett J., et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol 12 (1994) 1607-1615
7. Rogers L., Pueschel J., Spetzler R., et al. Is gross-total resection sufficient treatment for posterior fossa ependymomas?. J Neurosurg 102 (2005) 629-636
8. Copeland D., deMoor C., Moore III B., and Ater J. Neurocognitive development of children after a cerebellar tumor in infancy: a longitudinal study. J Clin Oncol 17 (1999) 3476-3486
9. Mulhern R., Merchant T., Gajjar A., Reddick W., and Kun L. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5 (2004) 399-408
10. Riva D., and Giorgi C. The neurodevelopmental price of survival in children with malignant brain tumours. Childs Nerv Syst 16 (2000) 751-754
11. Spiegler B., Bouffet E., Greenberg M., Rutka J., and Mabbott D. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 22 (2004) 706-713
12. Duffner P., Krischer J., Horowitz M., et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol 44 (1998) 313-316
13. Lannering B., Marky I., Lundberg A., and Olsson E. Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Med Pediatr Oncol 18 (1990) 304-310
14. Spoudeas H., and Kirkham F. Toxicity and late effects. In: Walker D., Perilongo G., Punt J., and Taylor R. (Eds). Brain and spine tumours of childhood (2004), Arnold, London 433-462
15. White L., Kellie S., Gray E., et al. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG). J Pediatr Hematol Oncol 20 (1998) 125-130
16. Lashford L., Campbell R., Gattamaneni H., et al. An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children. Arch Dis Child 74 (1996) 219-223
17. Gnekow A. Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology. Med Pediatr Oncol 24 (1995) 104-108
18. Wiestler O., Schiffer D., Coons S., Prayson R., and Rosenblum M. Ependymoma. In: Kleihues P. (Ed). Pathology and genetics of tumours of the nervous system (2000), IARC, Lyon 71-81
19. Tai B.-C., White I., Gebski V., and Machin D. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. Stat Med 20 (2001) 661-684
20. Machin D., Chung Y.-B., and Parmar M. Survival analysis: a practical approach. 2nd edn. (2006), Wiley, Chichester
21. Lewis I., Weeden S., Machin D., Stark D., and Craft A. Received dose and dose-intensity of chemotherapy in non metastatic extremity osteosarcoma. J Clin Oncol 18 (2000) 4028-4037
22. Duffner P., Krischer J., Sanford R., et al. Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 28 (1998) 215-222
23. Goldwein J., Glauser T., Packer R., et al. Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66 (1990) 557-563
24. Rousseau P., Habrand J., Sarrazin D., et al. Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 28 (1994) 381-386
25. Grundy R., Machin D., Weston C., et al. The role of chemotherapy in intracranial ependymoma in young children: a European meta-analysis. Neuro-Oncol 9 (2007) 217
26. Perilongo G., Massimino M., Sotti G., et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol 29 (1997) 79-85
27. Pollack I., Gerszten P., Martinez A., et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37 (1995) 655-666
28. Robertson P., Zeltzer P., Boyett J., et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 88 (1998) 695-703
29. Goldwein J., Leahy J., Packer R., et al. Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys 19 (1990) 1497-1502
30. Sutton L., Goldwein J., Perilongo G., et al. Prognostic factors in childhood ependymomas. Pediatr Neurosurg 16 (1990) 57-65
31. Korshunov A., Golanov A., Sycheva R., and Timirgaz V. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients. Cancer 100 (2004) 1230-1237
32. Figarella-Branger D., Civatte M., Bouvier-Labit C., et al. Prognostic factors in intracranial ependymomas in children. J Neurosurg 93 (2000) 605-613
33. Horn B., Heideman R., Geyer R., et al. A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol 21 (1999) 203-211
34. Timmermann B., Kortmann R., Kuhl J., et al. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 46 (2000) 287-295
35. Poltinnikov I., and Merchant T. CSF cytology has limited value in the evaluation of patients with ependymoma who have MRI evidence of metastasis. Paediatr Blood Cancer 47 (2006) 169-173
36. Peet A., Leach M., Pinkerton C., Price P., Williams S., and Grundy R. The development of functional imaging in the diagnosis, management and understanding of childhood brain tumours. Pediatr Blood Cancer 44 (2006) 103-113
37. Weitman S., Frazier K., and Kamen B. The folate receptor in central nervous system malignancies of childhood. J Neurooncol 21 (1994) 107-112
38. Gumley D., Phipps K., Reynolds J., and Michalski A. Infants with ependymoma: Outcome following surgery and baby brain chemotherapy. Neuro-Oncol 6 (2004) 457
39. Abelson H. Methotrexate and central nervous system toxicity. Cancer Treat Rep 62 (1978) 1999-2001
40. Bleyer W. Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 65 suppl 1 (1981) 89-98
41. Allen J., Rosen G., Mehta B., and Horten B. Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 64 (1980) 1261-1273
42. Kellie S., Chaku J., Lockwood L., O'Regan P., Waters K., and Wong C. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy. Eur J Cancer 41 (2005) 1588-1596
43. Rutkowski S., Bode U., Deinlein F., et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352 (2005) 978-986
44. Allen J., Walker R., and Rosen G. Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors. J Clin Oncol 6 (1988) 649-653
45. van Veelen-Vincent M., Pierre-Kahn A., Kalifa C., et al. Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg 97 (2002) 827-835
46. Salazar O., Castro-Vita H., VanHoutte P., Rubin P., and Aygun C. Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. J Neurosurg 59 (1983) 652-659
47. Shaw E., Evans R., Scheithauer B., Ilstrup D., and Earle J. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13 (1987) 1457-1462